Patents Assigned to MYOCEPT INC.
  • Patent number: 11752086
    Abstract: The invention provides topical formulations and methods comprising charged bioactive agents complexed with amphipol polymers for dermal and transdermal delivery, optionally further including TJ-modulating peptides.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: September 12, 2023
    Assignee: MYOCEPT INC.
    Inventor: Lars Erik Peters
  • Publication number: 20200009040
    Abstract: The invention provides topical formulations and methods comprising charged bioactive agents complexed with amphipol polymers for dermal and transdermal delivery, optionally further including TJ-modulating peptides.
    Type: Application
    Filed: February 7, 2018
    Publication date: January 9, 2020
    Applicant: MYOCEPT INC.
    Inventor: Lars Erik PETERS
  • Patent number: 9815875
    Abstract: Improved chemodenervation agents are provided comprising polypeptide ?-neurotoxins having high binding specificity and selectivity for the human muscular ?1 nAChR instead of the human neuronal ?7 nAChR, along with pharmaceutical compositions and methods of use.
    Type: Grant
    Filed: February 19, 2009
    Date of Patent: November 14, 2017
    Assignee: MYOCEPT INC.
    Inventors: Lars Erik Peters, Todd Lorenz